First Psychedelic Trial Clinic Set to Launch in London
Clerkenwell Health, a start-up based in the United Kingdom, plans to open a commercial facility for carrying out drug trials on psychedelics in London. This facility will be the first in Europe to be launched for this particular purpose. The company plans to start trials that will focus on the potential for psychedelic drugs in treating mental health conditions, including end-of-life anxiety, nicotine dependency and post-traumatic stress disorder, by August. In a recent interview, Clerkenwell Health CEO Tom McDonald stated that the United Kingdom was well positioned to be at the forefront of psychedelic-assisted therapy as a global leader in…